Anda belum login :: 23 Nov 2024 08:06 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide
Oleh:
Shastri, Shefali M.
;
Barbieri, Elizabeth
;
Kligman, Isaac
;
Schoyer, Katherine D.
;
Davis, Owen K.
;
Rosenwaks, Zev
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 95 no. 02 (Feb. 2011)
,
page 592-595 .
Topik:
FERTILITY
;
Estrogen priming
;
IVF failure
;
GnRH antagonist
;
poor responder
Ketersediaan
Perpustakaan FK
Nomor Panggil:
F02.K.2011.02
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Objective To evaluate in vitro fertilization (IVF) cycle outcomes in young poor responders treated with a luteal estradiol/gonadotropin-releasing hormone antagonist (E2/ANT) protocol versus an oral contraceptive pill microdose leuprolide protocol (OCP-MDL). Design Retrospective cohort. Setting Academic practice. Patient(s) Poor responders: 186 women, aged <35 years undergoing IVF with either E2/ANT or OCP-MDL protocols. Intervention(s) None. Main Outcome Measure(s) Clinical pregnancies, oocytes retrieved, cancellation rate. Result(s) Patients in the E2/ANT group had a greater gonadotropin requirement (71.9 ± 22.2 vs. 57.6 ± 25.7) and lower E2 level (1,178.6 ± 668 vs. 1,627 ± 889), yet achieved similar numbers of oocytes retrieved and fertilized, and a greater number of embryos transferred (2.3 ± 0.9 vs. 2.0 ± 1.1) with a better mean grade (2.14 ± .06 vs. 2.7 ± 1.8) compared with the OCP/MDL group. The E2/ANT group exhibited a trend toward improved implantation rates (30.5% vs. 21.1%) and ongoing pregnancy rates per started cycle: 44 out of 117 (37%) versus 17 out of 69 (25%). Conclusion(s) Poor responders aged <35 years may be treated with the aggressive E2/ANT protocol to improve cycle outcomes. Both protocols remain viable options for this group. Adequately powered, randomized clinical comparison appears justified.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)